Clinical Trial: Study of M5049 in DM and PM Participants (NEPTUNIA)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Dermatomyositis
Study Type: INTERVENTIONAL
Official Title: A Phase IIa, Randomized, Parallel, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Enpatoran in Dermatomyositis and Polymyositis Participants Receiving Standard of Care (
Brief Summary:
The purpose of this study is to evaluate the efficacy and safety of orally administered M5049 in idiopathic inflammatory myopathies, specifically dermatomyositis (DM) and polymyositis (PM) participants for 24 weeks.
Read more